Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 Mutations

Conditions:   Cholangiocarcinoma;   Chondrosarcoma;   Glioma;   Any Solid Tumor Intervention:   Drug: LY3410738 Sponsors:   Loxo Oncology, Inc.;   Eli Lilly and Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials